Inhibition of InsP3R with Xestospongin B Reduces Mitochondrial Respiration and Induces Selective Cell Death in T Cell Acute Lymphoblastic Leukemia Cells

Autor: Daniela Sauma, Alenka Lovy, Galdo Bustos, Ulises Ahumada-Castro, César Cárdenas, Jordi Molgó, Pablo Cruz
Přispěvatelé: Universidad Mayor [Santiago de Chile], Service d'Ingénierie Moléculaire pour la Santé (ex SIMOPRO) (SIMoS), Médicaments et Technologies pour la Santé (MTS), Université Paris-Saclay-Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE)-Université Paris-Saclay-Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Universidad de Chile = University of Chile [Santiago] (UCHILE), University of California [Santa Barbara] (UC Santa Barbara), University of California (UC), This research was funded by FONDECYT #1200255, 1180385, CONICYT/FONDAP # 15150012 and CONICYT Doctoral Fellowship Program funds PC (#21180306)
Jazyk: angličtina
Rok vydání: 2021
Předmět:
MESH: Cell Death
0301 basic medicine
Mitochondrion
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
bioenergetics
Jurkat cells
lcsh:Chemistry
chemistry.chemical_compound
MESH: Macrocyclic Compounds
0302 clinical medicine
Inositol 1
4
5-Trisphosphate Receptors

Inositol
Receptor
Oxazoles
lcsh:QH301-705.5
Spectroscopy
Cell Death
MESH: Oxazoles
[SDV.MHEP.HEM]Life Sciences [q-bio]/Human health and pathology/Hematology
General Medicine
Computer Science Applications
Mitochondria
MESH: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
MESH: Leukocytes
Mononuclear

medicine.anatomical_structure
030220 oncology & carcinogenesis
T-ALL
Programmed cell death
MESH: Cell Line
Tumor

Macrocyclic Compounds
MESH: Mitochondria
T cell
Cell Respiration
[SDV.CAN]Life Sciences [q-bio]/Cancer
Catalysis
Article
Inorganic Chemistry
03 medical and health sciences
MESH: Inositol 1
4
5-Trisphosphate Receptors

Cell Line
Tumor

medicine
Humans
cancer
Physical and Theoretical Chemistry
Molecular Biology
MESH: Humans
calcium
Endoplasmic reticulum
Organic Chemistry
030104 developmental biology
chemistry
lcsh:Biology (General)
lcsh:QD1-999
Cell culture
MESH: Biomarkers
[SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology
Cancer research
Leukocytes
Mononuclear

MESH: Cell Respiration
metabolism
Biomarkers
Zdroj: International Journal of Molecular Sciences, Vol 22, Iss 651, p 651 (2021)
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 2021, 22 (2), pp.651. ⟨10.3390/ijms22020651⟩
Volume 22
Issue 2
ISSN: 1661-6596
1422-0067
DOI: 10.3390/ijms22020651⟩
Popis: International audience; T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematological malignancy whose chemoresistance and relapse persist as a problem despite significant advances in its chemotherapeutic treatments. Mitochondrial metabolism has emerged as an interesting therapeutic target given its essential role in maintaining bioenergetic and metabolic homeostasis. T-ALL cells are characterized by high levels of mitochondrial respiration, making them suitable for this type of intervention. Mitochondrial function is sustained by a constitutive transfer of calcium from the endoplasmic reticulum to mitochondria through the inositol 1,4,5-trisphosphate receptor (InsP3R), making T-ALL cells vulnerable to its inhibition. Here, we determine the bioenergetic profile of the T-ALL cell lines CCRF-CEM and Jurkat and evaluate their sensitivity to InsP3R inhibition with the specific inhibitor, Xestospongin B (XeB). Our results show that T-ALL cell lines exhibit higher mitochondrial respiration than non-malignant cells, which is blunted by the inhibition of the InsP3R. Prolonged treatment with XeB causes T-ALL cell death without affecting the normal counterpart. Moreover, the combination of XeB and glucocorticoids significantly enhanced cell death in the CCRF-CEM cells. The inhibition of InsP3R with XeB rises as a potential therapeutic alternative for the treatment of T-ALL.
Databáze: OpenAIRE